These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 35458476)
1. COVID-19 in Elderly, Immunocompromised or Diabetic Patients-From Immune Monitoring to Clinical Management in the Hospital. Wünsch K; Anastasiou OE; Alt M; Brochhagen L; Cherneha M; Thümmler L; van Baal L; Madel RJ; Lindemann M; Taube C; Witzke O; Rohn H; Krawczyk A; Jansen S Viruses; 2022 Apr; 14(4):. PubMed ID: 35458476 [TBL] [Abstract][Full Text] [Related]
2. Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa. Meiring S; Tempia S; Bhiman JN; Buys A; Kleynhans J; Makhasi M; McMorrow M; Moyes J; Quan V; Walaza S; du Plessis M; Wolter N; von Gottberg A; Cohen C; Clin Infect Dis; 2022 Aug; 75(1):e144-e156. PubMed ID: 35134129 [TBL] [Abstract][Full Text] [Related]
3. Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment. Thümmler L; Konik M; Lindemann M; Fisenkci N; Koldehoff M; Gäckler A; Horn PA; Theodoropoulos F; Taube C; Zettler M; Anastasiou OE; Braß P; Jansen S; Witzke O; Rohn H; Krawczyk A Front Immunol; 2022; 13():980698. PubMed ID: 36311723 [TBL] [Abstract][Full Text] [Related]
4. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report. Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity. Wei J; Zhao J; Han M; Meng F; Zhou J J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811 [TBL] [Abstract][Full Text] [Related]
6. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results. Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791 [TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study. Dopfer-Jablonka A; Steffens S; Müller F; Mikuteit M; Niewolik J; Cossmann A; Stankov MV; Behrens GMN; Hummers E; Heesen G; Schröder D; Roder S; Klawonn F; Vahldiek K; Hasenkamp J; Kallusky J; Falk CS; Overbeck TR; Heinemann S BMC Infect Dis; 2022 Apr; 22(1):403. PubMed ID: 35468758 [TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients. Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469 [TBL] [Abstract][Full Text] [Related]
11. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Lampasona V; Secchi M; Scavini M; Bazzigaluppi E; Brigatti C; Marzinotto I; Davalli A; Caretto A; Laurenzi A; Martinenghi S; Molinari C; Vitali G; Di Filippo L; Mercalli A; Melzi R; Tresoldi C; Rovere-Querini P; Landoni G; Ciceri F; Bosi E; Piemonti L Diabetologia; 2020 Dec; 63(12):2548-2558. PubMed ID: 33029657 [TBL] [Abstract][Full Text] [Related]
12. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19). Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376 [TBL] [Abstract][Full Text] [Related]
13. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation? Rhee C; Kanjilal S; Baker M; Klompas M Clin Infect Dis; 2021 Apr; 72(8):1467-1474. PubMed ID: 33029620 [TBL] [Abstract][Full Text] [Related]
14. Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020. Kotwa JD; Jamal AJ; Mbareche H; Yip L; Aftanas P; Barati S; Bell NG; Bryce E; Coomes E; Crowl G; Duchaine C; Faheem A; Farooqi L; Hiebert R; Katz K; Khan S; Kozak R; Li AX; Mistry HP; Mozafarihashjin M; Nasir JA; Nirmalarajah K; Panousis EM; Paterson A; Plenderleith S; Powis J; Prost K; Schryer R; Taylor M; Veillette M; Wong T; Zoe Zhong X; McArthur AG; McGeer AJ; Mubareka S J Infect Dis; 2022 Mar; 225(5):768-776. PubMed ID: 34850051 [TBL] [Abstract][Full Text] [Related]
15. Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era. Götz V; Mathé P; Agarwal P; Hornuss D; Pfau S; Panning M; Prager E; Voll RE; Engelhardt M; Frye BC; Bamberg F; Fuchs J; Müller M; Wagner D; Rieg S Infection; 2024 Jun; 52(3):923-933. PubMed ID: 38095753 [TBL] [Abstract][Full Text] [Related]
16. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting. Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436 [TBL] [Abstract][Full Text] [Related]
18. COVID-19: a conundrum to decipher. Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923 [TBL] [Abstract][Full Text] [Related]
19. Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center. Freeman MC; Rapsinski GJ; Zilla ML; Wheeler SE J Pediatric Infect Dis Soc; 2021 Apr; 10(4):426-431. PubMed ID: 33049042 [TBL] [Abstract][Full Text] [Related]
20. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]